(Q40809939)

English

Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: Complementary Statement from the International Mesothelioma Interest Group, Also Endorsed by the International Academy of Cytology and the Papanicolaou

scientific article published on July 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: Complementary Statement from the International Mesothelioma Interest Group, Also Endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

based on heuristic

inferred from title

Tadao K Kobayashi

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Jenette Creaney

5

object named as

Jenette Creaney

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

Anders Hjerpe

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Valeria Ascoli

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Carlos W M Bedrossian

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Mathilde E Boon

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Ben Davidson

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Annika Dejmek

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Katalin Dobra

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Ambrogio Fassina

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Andrew Field

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Pinar Firat

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Toshiaki Kamei

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Claire W Michael

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Sevgen Önder

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Amanda Segal

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Philippe Vielh

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

International Mesothelioma Interest Group

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

International Academy of Cytology

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

publication date

1 July 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Diagnostic Cytopathology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

43

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

563-576

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma.

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

The diagnosis of malignant mesothelioma in effusion cytology: a reappraisal and results of a multi-institution survey

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

Should cytology be an acceptable means of diagnosing malignant mesothelioma?

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

The cytology of malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

Multimodality treatment of diffuse malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

The implementation of liquid-based cytology for lung and pleural-based diseases

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

A Rapid and Simple Method for Electron Microscopy of Paraffin-Embedded Tissue

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

How useful is GLUT-1 in differentiating mesothelial hyperplasia and fibrosing pleuritis from epithelioid and sarcomatoid mesotheliomas? An international collaborative study.

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

Well-differentiated papillary mesothelioma with invasive foci.

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

Well-differentiated papillary mesothelioma, possibly giving rise to diffuse malignant mesothelioma: a case report

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

Hyaluronic acid in the pleural fluid of patients with malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

Hyaluronan and N-ERC/mesothelin as key biomarkers in a specific two-step model to predict pleural malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

Repertoire of human natural anti-glycan immunoglobulins. Do we have auto-antibodies?

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

Telomerase activity analyzed with TRAP in situ provides additional information in effusions remaining equivocal after immunocytochemistry and hyaluronan analysis.

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions.

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

Pleural fluid cytological yield and visceral pleural invasion in patients with epithelioid malignant pleural mesothelioma.

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

Mesothelin-family proteins and diagnosis of mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

21 January 2018

A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

7 January 2021

based on heuristic

inferred from DOI database lookup

Malignant pleural mesothelioma: a comprehensive review

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytologic diagnosis of malignant mesothelioma, with particular emphasis on the epithelial noncohesive cell type

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

7 January 2021

based on heuristic

inferred from DOI database lookup

"Thick" cell membranes revealed by immunocytochemical staining: a clue to the diagnosis of mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

7 January 2021

based on heuristic

inferred from DOI database lookup

Carcinoembryonic antigen-like reactivity in malignant mesothelioma. A comparison between different commercially available antibodies

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactivity of six antibodies in effusions of mesothelioma, adenocarcinoma and mesotheliosis: stepwise logistic regression analysis

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

7 January 2021

based on heuristic

inferred from DOI database lookup

The value of epithelial membrane antigen expression in separating benign mesothelial proliferation from malignant mesothelioma: a comparative study

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative immunohistochemical analysis of IMP3, GLUT1, EMA, CD146, and desmin for distinguishing malignant mesothelioma from reactive mesothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic value of fluorescence in situ hybridization assay in malignant mesothelioma: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

7 January 2021

based on heuristic

inferred from DOI database lookup

Telomere repeat amplification protocol (TRAP) in situ reveals telomerase activity in three cell types in effusions: malignant cells, proliferative mesothelial cells, and lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FDC.23271

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DC.23271

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26100969%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40809939&oldid=2098934780"